Search

everythinglearnresearchcommunity

for

Search:↓

Activating β-catenin increases melanocytes and decreases Schwann cells.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

The combination treatment showed a higher response rate but no significant survival benefits.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

The document lists various dermatology topics, treatments, and diagnostic methods.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Iron deficiency may contribute to hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

A person with a specific gene mutation had extra teeth, unique jaw and hair features not seen before in this condition.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.